PubMed

Maintenance therapy with once-monthly administration of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder: a pilot study of an extended dosing interval.

Gharabawi GM, Gearhart NC, Lasser RA, Mahmoud RA, Zhu Y, Mannaert E, Naessens I, Bossie CA, Kujawa M, Simpson GM.

Ann Gen Psychiatry. 2007 Jan 29;6:3.PMID: 17261186 [PubMed]Free PMC ArticleFree textRelated citations

Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.

Lindenmayer JP, Eerdekens E, Berry SA, Eerdekens M.

J Clin Psychiatry. 2004 Aug;65(8):1084-9.PMID: 15323593 [PubMed - indexed for MEDLINE]Related citations

Efficacy and safety of long-acting risperidone in stable patients with schizoaffective disorder.

Lasser R, Bossie CA, Gharabawi G, Eerdekens M, Nasrallah HA.

J Affect Disord. 2004 Dec;83(2-3):263-75.PMID: 15555724 [PubMed - indexed for MEDLINE]Related citations

Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder.

Lasser RA, Bossie CA, Zhu Y, Gharabawi G, Eerdekens M, Davidson M.

Int J Geriatr Psychiatry. 2004 Sep;19(9):898-905.PMID: 15352149 [PubMed - indexed for MEDLINE]Related citations

Long-term safety and tolerability of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder.

Lindenmayer JP, Khan A, Eerdekens M, Van Hove I, Kushner S.

Eur Neuropsychopharmacol. 2007 Jan 15;17(2):138-44. Epub 2006 Oct 17.PMID: 17049818 [PubMed - indexed for MEDLINE]Related citations

A 1-year double-blind study of 2 doses of long-acting risperidone in stable patients with schizophrenia or schizoaffective disorder.

Simpson GM, Mahmoud RA, Lasser RA, Kujawa M, Bossie CA, Turkoz I, Rodriguez S, Gharabawi GM.

J Clin Psychiatry. 2006 Aug;67(8):1194-203.PMID: 16965196 [PubMed - indexed for MEDLINE]Related citations

Patients with schizophrenia previously stabilized on conventional depot antipsychotics experience significant clinical improvements following treatment with long-acting risperidone.

Lasser RA, Bossie CA, Gharabawi GM, Turner M.

Eur Psychiatry. 2004 Jun;19(4):219-25.PMID: 15196604 [PubMed - indexed for MEDLINE]Related citations

Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic.

Fleischhacker WW, Eerdekens M, Karcher K, Remington G, Llorca PM, Chrzanowski W, Martin S, Gefvert O.

J Clin Psychiatry. 2003 Oct;64(10):1250-7.PMID: 14658976 [PubMed - indexed for MEDLINE]Related citations

Monthly administration of long-acting injectable risperidone and striatal dopamine D2 receptor occupancy for the management of schizophrenia.

Uchida H, Mamo DC, Kapur S, Labelle A, Shammi C, Mannaert EJ, Mann SW, Remington G.

J Clin Psychiatry. 2008 Aug;69(8):1281-6.PMID: 18642974 [PubMed - indexed for MEDLINE]Related citations

Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Clin Ther. 2008 Dec;30(12):2378-86.PMID: 19167596 [PubMed - indexed for MEDLINE]Related citations

Risperidone long-acting injection (RLAI): the 12-week efficacy and tolerability in Thai patients with chronic schizophrenia.

Arunpongpaisal S, Srisurapanont M, Kongsakon R, Kitiwattanagul K, Samanwongthai U.

J Med Assoc Thai. 2010 Mar;93(3):343-50.PMID: 20420110 [PubMed - indexed for MEDLINE]Related citations

Long-acting risperidone in stable patients with schizoaffective disorder.

Mohl A, Westlye K, Opjordsmoen S, Lex A, Schreiner A, Benoit M, Bräunig P, Medori R.

J Psychopharmacol. 2005 Sep;19(5 Suppl):22-31.PMID: 16144783 [PubMed - indexed for MEDLINE]Related citations

Long-acting injectable risperidone v. olanzapine tablets for schizophrenia or schizoaffective disorder. Randomised, controlled, open-label study.

Keks NA, Ingham M, Khan A, Karcher K.

Br J Psychiatry. 2007 Aug;191:131-9.PMID: 17666497 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Lack of impact of race on the efficacy and safety of long-acting risperidone versus placebo in patients with schizophrenia or schizoaffective disorder.

Ciliberto N, Bossie CA, Urioste R, Lasser RA.

Int Clin Psychopharmacol. 2005 Jul;20(4):207-12.PMID: 15933481 [PubMed - indexed for MEDLINE]Related citations

Improvements in stable patients with psychotic disorders switched from oral conventional antipsychotics therapy to long-acting risperidone.

van Os J, Bossie CA, Lasser RA.

Int Clin Psychopharmacol. 2004 Jul;19(4):229-32.PMID: 15201570 [PubMed - indexed for MEDLINE]Related citations

Remission in schizophrenia: Results from a 1-year study of long-acting risperidone injection.

Lasser RA, Bossie CA, Gharabawi GM, Kane JM.

Schizophr Res. 2005 Sep 15;77(2-3):215-27.PMID: 15908183 [PubMed - indexed for MEDLINE]Related citations

Long-acting risperidone injection.

Love RC, Conley RJ.

Am J Health Syst Pharm. 2004 Sep 1;61(17):1792-800. Review.PMID: 15462250 [PubMed - indexed for MEDLINE]Related citations

Insight and its relationship to clinical outcomes in patients with schizophrenia or schizoaffective disorder receiving long-acting risperidone.

Gharabawi GM, Lasser RA, Bossie CA, Zhu Y, Amador X.

Int Clin Psychopharmacol. 2006 Jul;21(4):233-40.PMID: 16687995 [PubMed - indexed for MEDLINE]Related citations

Efficacy and safety of risperidone long-acting injectable in stable psychotic patients previously treated with oral risperidone.

Schmauss M, Sacchetti E, Kahn JP, Medori R.

Int Clin Psychopharmacol. 2007 Mar;22(2):85-92. Erratum in: Int Clin Psychopharmacol. 2007 Sep;22(5):312. PMID: 17293708 [PubMed - indexed for MEDLINE]Related citations

Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder.

Rossi A, Bagalà A, Del Curatolo V, Scapati F, Bernareggi MM, Giustra MG; Risperidone Long-Acting Trial Investigators (R-LAI).

Hum Psychopharmacol. 2009 Oct;24(7):574-83.PMID: 19790173 [PubMed - indexed for MEDLINE]Related citations